HK Stock MarketDetailed Quotes

02616 CSTONE PHARMA-B

Watchlist
  • 1.200
  • +0.010+0.84%
Market Closed Jul 26 16:08 CST
1.54BMarket Cap-3797P/E (TTM)

CSTONE PHARMA-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CSTONE PHARMA-B Earnings Date

Currency: CNY

Period

FY2023 Annual Report

--

Revenue(YoY)

463.84M

-3.64%
EPS(YoY)

-0.29

+61.80%
Analyst Rating

Strong Buy

Jul 26, 2024

CSTONE PHARMA-B Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2023/H2202.368M / 373.425M--
Aug 15, 20232023/H1261.474M / 355.796M--
--2022/H2219.598M / 219.598M--
Aug 25, 20222022/H1261.765M / 261.765M--
May 30, 20222021/H2164.269M / 187.652M--
DatePeriodRevenue/EstimateEarnings Call
--2023/H2202.368M / 373.425M--
Aug 15, 20232023/H1261.474M / 355.796M--
--2022/H2219.598M / 219.598M--
Aug 25, 20222022/H1261.765M / 261.765M--
May 30, 20222021/H2164.269M / 187.652M--

Unlock Free Earnings Estimates

CSTONE PHARMA-B Earnings Reports

  • CSTONE PHARMA-B: 2023 ANNUAL REPORT

    Apr 23 05:00 ET

  • CSTONE PHARMA-B: ANNOUNCEMENT OF ANNUAL RESULTSFOR THE YEAR ENDED DECEMBER 31, 2023

    Mar 27 08:43 ET

  • CSTONE PHARMA-B: DATE OF BOARD MEETING

    Mar 14 05:00 ET

  • CSTONE PHARMA-B: INTERIM REPORT 2023

    Sep 25, 2023 05:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 26, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    HK
    Overall
    Symbol
    Latest Price
    % Chg